Skip to main content
Addgene
Open Menu

Enter a sequence to perform a BLAST-based search of Addgene plasmid sequence databases.

Information

In Category

Filter By

We narrowed to 17,881 results for: puromycin

Clear keywords
Showing: 3081 - 3100 of 17881 results

  1. pLEX307-puro-SARS-CoV-2-nsp4-nsp5-T21I-nsp6

    Plasmid
    #247703
    Purpose
    Constitutive expression of SARS-CoV-2 nsp5 with T21I mutation fused to nsp4 and an N-terminal fragment of nsp6 under EF1-alpha promoter with puromycin resistance.
    Depositor
    Sho Iketani
    Publication
    Chithelen et al Nat Commun. 2026 May 19;17(1):6575. doi:
    Insert
    SARS-CoV-2 3CL protease with T21I fused to nsp4 and nsp6
    Use
    Lentiviral
    Expression
    Mammalian
    Mutation
    T21I
    Promoter
    EF1a
    Available since
    July 20, 2026
    Availability
    Academic Institutions and Nonprofits only
    247703-plasmid-map-sequence-id-491576

    Enlarge

  2. pLEX307-puro-SARS-CoV-2-nsp4-nsp5-L50F-nsp6

    Plasmid
    #247704
    Purpose
    Constitutive expression of SARS-CoV-2 nsp5 with L50F mutation fused to nsp4 and an N-terminal fragment of nsp6 under EF1-alpha promoter with puromycin resistance.
    Depositor
    Sho Iketani
    Publication
    Chithelen et al Nat Commun. 2026 May 19;17(1):6575. doi:
    Insert
    SARS-CoV-2 3CL protease with L50F fused to nsp4 and nsp6
    Use
    Lentiviral
    Expression
    Mammalian
    Mutation
    L50F
    Promoter
    EF1a
    Available since
    July 20, 2026
    Availability
    Academic Institutions and Nonprofits only
    247704-plasmid-map-sequence-id-503235

    Enlarge

  3. pLEX307-puro-SARS-CoV-2-nsp4-nsp5-E166V-nsp6

    Plasmid
    #247705
    Purpose
    Constitutive expression of SARS-CoV-2 nsp5 with E166V mutation fused to nsp4 and an N-terminal fragment of nsp6 under EF1-alpha promoter with puromycin resistance.
    Depositor
    Sho Iketani
    Publication
    Chithelen et al Nat Commun. 2026 May 19;17(1):6575. doi:
    Insert
    SARS-CoV-2 3CL protease with E166V fused to nsp4 and nsp6
    Use
    Lentiviral
    Expression
    Mammalian
    Mutation
    E166V
    Promoter
    EF1a
    Available since
    July 20, 2026
    Availability
    Academic Institutions and Nonprofits only
    247705-plasmid-map-sequence-id-491573

    Enlarge

  4. pLEX307-puro-SARS-CoV-2-nsp4-nsp5-E166A-nsp6

    Plasmid
    #247706
    Purpose
    Constitutive expression of SARS-CoV-2 nsp5 with E166A mutation fused to nsp4 and an N-terminal fragment of nsp6 under EF1-alpha promoter with puromycin resistance.
    Depositor
    Sho Iketani
    Publication
    Chithelen et al Nat Commun. 2026 May 19;17(1):6575. doi:
    Insert
    SARS-CoV-2 3CL protease with E166A fused to nsp4 and nsp6
    Use
    Lentiviral
    Expression
    Mammalian
    Mutation
    E166A
    Promoter
    EF1a
    Available since
    July 20, 2026
    Availability
    Academic Institutions and Nonprofits only
    247706-plasmid-map-sequence-id-491574

    Enlarge

  5. pLEX307-puro-SARS-CoV-2-nsp4-nsp5-S144A-nsp6

    Plasmid
    #247707
    Purpose
    Constitutive expression of SARS-CoV-2 nsp5 with S144A mutation fused to nsp4 and an N-terminal fragment of nsp6 under EF1-alpha promoter with puromycin resistance.
    Depositor
    Sho Iketani
    Publication
    Chithelen et al Nat Commun. 2026 May 19;17(1):6575. doi:
    Insert
    SARS-CoV-2 3CL protease with S144A fused to nsp4 and nsp6
    Use
    Lentiviral
    Expression
    Mammalian
    Mutation
    S144A
    Promoter
    EF1a
    Available since
    July 20, 2026
    Availability
    Academic Institutions and Nonprofits only
    247707-plasmid-map-sequence-id-503505

    Enlarge

  6. pLEX307-puro-SARS-CoV-2-nsp4-nsp5-T304I-nsp6

    Plasmid
    #247708
    Purpose
    Constitutive expression of SARS-CoV-2 nsp5 with T304I mutation fused to nsp4 and an N-terminal fragment of nsp6 under EF1-alpha promoter with puromycin resistance.
    Depositor
    Sho Iketani
    Publication
    Chithelen et al Nat Commun. 2026 May 19;17(1):6575. doi:
    Insert
    SARS-CoV-2 3CL protease with T304I fused to nsp4 and nsp6
    Use
    Lentiviral
    Expression
    Mammalian
    Mutation
    T304I
    Promoter
    EF1a
    Available since
    July 20, 2026
    Availability
    Academic Institutions and Nonprofits only
    247708-plasmid-map-sequence-id-501776

    Enlarge

  10. pPD1178-LPDV promoterless PuroR-P2A-miRFP720

    Plasmid
    #201537
    Purpose
    Landing pad destination vector for mMoClo golden gate-based assembly of landing pad integration vectors; contains BxB1 attB site, promoterless puromycin resistance gene and miRFP720 gene
    Depositor
    Joshua Leonard
    Publication
    Peruzzi et al Nat Commun. 2024 Jul 4;15(1):5618. doi:
    Insert
    Promoterless PuroR-P2A-miRFP720
    Expression
    Mammalian
    Promoter
    None
    Available since
    Dec. 19, 2024
    Availability
    Academic Institutions and Nonprofits only
    201537-plasmid-map-sequence-id-401330

    Enlarge

  12. pLV-EF1A-WWE-HA-nLuc-FLAG-T2A-WWE-myc-cLuc-FLAG-IRES-Puro

    Plasmid
    #187611
    Purpose
    Split luciferase construct with nLuc fused to C-terminus of WWE domain, linked by T2A to cLuc fused to C-terminus of WWE domain, linked by IRES to puromycin resistance cassette
    Depositor
    Robert Sobol
    Publication
    Koczor et al Cancers (Basel). 2022 Jul 28;14(15). pii
    Inserts
    WWE domain with C-terminal nLuc
    WWE domain with C-terminal cLuc
    Use
    Lentiviral
    Tags
    FLAG, HA, Split luciferase (cLuc), Split lucifera…
    Expression
    Mammalian
    Promoter
    EF1A
    Available since
    Sept. 15, 2022
    Availability
    Academic Institutions and Nonprofits only
    187611-plasmid-map-sequence-id-372189

    Enlarge

  13. pLV-EF1A-WWE(R163A)-HA-nLuc-FLAG-T2A-WWE-myc-cLuc-FLAG-IRES-Puro

    Plasmid
    #187612
    Purpose
    Split luciferase construct with nLuc fused to C-terminus of WWE domain with Arg163Ala mutation, linked by T2A to cLuc fused to C-terminus of WWE domain, linked by IRES to puromycin resistance cassette
    Depositor
    Robert Sobol
    Publication
    Koczor et al Cancers (Basel). 2022 Jul 28;14(15). pii
    Inserts
    WWE domain (R163A) with C-terminal nLuc
    WWE domain with C-terminal cLuc
    Use
    Lentiviral
    Tags
    FLAG, HA, Split luciferase (cLuc), Split lucifera…
    Expression
    Mammalian
    Mutation
    Arg163Ala
    Promoter
    EF1A
    Available since
    Sept. 14, 2022
    Availability
    Academic Institutions and Nonprofits only
    187612-plasmid-map-sequence-id-372035

    Enlarge

  14. pYL237

    Plasmid
    #173194
    Purpose
    CRISPR donor plasmid for making the RNA-binding mutant EZH2 control cell line. It contains a puromycin resistance gene and an mCherry gene
    Depositor
    Thomas Cech
    Publication
    Long et al Nat Genet. 2020 Sep;52(9):931-938. doi:
    Insert
    EZH2 RNA-binding mutant
    Use
    CRISPR
    Expression
    Mammalian
    Available since
    April 28, 2022
    Availability
    Academic Institutions and Nonprofits only
    173194-plasmid-map-sequence-id-360541

    Enlarge

  16. MO70-C-FLAG-hNKD2

    Plasmid
    #174327
    Purpose
    encodes human NKD2 cDNA with a C-terminal FLAG tag in retroviral expression vector. Encodes GFP from IRES site and puromycin resistance
    Depositor
    Sonal Srikanth
    Publication
    Wu et al Cell Rep. 2021 Aug 24;36(8):109603. doi:
    Insert
    Homo sapiens NKD inhibitor of WNT signaling pathway 2 (NKD2 Human)
    Use
    Retroviral
    Tags
    FLAG Tag
    Expression
    Mammalian
    Promoter
    CMV
    Available since
    Dec. 8, 2021
    Availability
    Academic Institutions and Nonprofits only
    174327-plasmid-map-sequence-id-349813

    Enlarge

Showing: 3081 - 3100 of 17881 results